MANDRIOLI, Jessica
 Distribuzione geografica
Continente #
NA - Nord America 22.618
AS - Asia 14.702
EU - Europa 10.536
SA - Sud America 3.399
AF - Africa 376
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 7
Totale 51.692
Nazione #
US - Stati Uniti d'America 22.166
SG - Singapore 4.350
CN - Cina 3.552
IT - Italia 2.971
BR - Brasile 2.618
HK - Hong Kong 2.390
GB - Regno Unito 2.138
VN - Vietnam 1.927
DE - Germania 989
SE - Svezia 977
FI - Finlandia 912
RU - Federazione Russa 601
KR - Corea 579
FR - Francia 360
BG - Bulgaria 333
IN - India 315
ID - Indonesia 314
AR - Argentina 312
NL - Olanda 258
UA - Ucraina 258
TR - Turchia 222
BD - Bangladesh 178
CA - Canada 164
MX - Messico 155
EC - Ecuador 130
IQ - Iraq 123
AT - Austria 114
JP - Giappone 112
ZA - Sudafrica 111
ES - Italia 91
CO - Colombia 90
LT - Lituania 81
PL - Polonia 79
PK - Pakistan 77
IE - Irlanda 73
CZ - Repubblica Ceca 70
PY - Paraguay 66
CL - Cile 63
MY - Malesia 63
AE - Emirati Arabi Uniti 62
BE - Belgio 54
EG - Egitto 50
MA - Marocco 50
PH - Filippine 50
AU - Australia 43
VE - Venezuela 43
SA - Arabia Saudita 40
UZ - Uzbekistan 39
TN - Tunisia 38
PE - Perù 35
AZ - Azerbaigian 33
KE - Kenya 33
DZ - Algeria 31
UY - Uruguay 29
CH - Svizzera 28
NP - Nepal 25
TH - Thailandia 24
IR - Iran 23
BZ - Belize 22
DO - Repubblica Dominicana 22
IL - Israele 22
TW - Taiwan 22
JM - Giamaica 21
RO - Romania 21
JO - Giordania 20
KZ - Kazakistan 20
PA - Panama 18
ET - Etiopia 16
OM - Oman 16
PT - Portogallo 16
CR - Costa Rica 15
PS - Palestinian Territory 15
GR - Grecia 13
GE - Georgia 12
BY - Bielorussia 11
LB - Libano 11
BH - Bahrain 10
BO - Bolivia 10
LV - Lettonia 10
TT - Trinidad e Tobago 10
AL - Albania 9
NG - Nigeria 9
KG - Kirghizistan 8
NZ - Nuova Zelanda 8
SI - Slovenia 8
BA - Bosnia-Erzegovina 7
CI - Costa d'Avorio 7
SK - Slovacchia (Repubblica Slovacca) 7
BB - Barbados 6
CY - Cipro 6
DK - Danimarca 6
EE - Estonia 6
QA - Qatar 6
SY - Repubblica araba siriana 6
GT - Guatemala 5
HR - Croazia 5
KH - Cambogia 5
LK - Sri Lanka 5
NO - Norvegia 5
RS - Serbia 5
Totale 51.594
Città #
Santa Clara 3.107
Singapore 2.834
Ashburn 2.624
Hong Kong 2.366
Fairfield 2.020
San Jose 1.041
Chandler 1.002
Hefei 958
Woodbridge 869
Southend 864
London 839
Houston 791
Helsinki 747
Seattle 704
Wilmington 674
Ho Chi Minh City 645
Nyköping 605
Beijing 599
Cambridge 578
Seoul 549
The Dalles 524
Los Angeles 443
Hanoi 419
Ann Arbor 416
Dearborn 392
Munich 385
Jacksonville 360
Council Bluffs 353
Chicago 345
Princeton 324
Sofia 321
Modena 311
Milan 299
New York 281
San Diego 272
São Paulo 232
Jakarta 200
Shanghai 175
Buffalo 171
Moscow 164
Rome 158
Lauterbourg 113
Salt Lake City 110
Dallas 96
Haiphong 93
Da Nang 92
Redondo Beach 92
Frankfurt am Main 89
Atlanta 85
Orem 85
Bologna 84
Rio de Janeiro 83
Eugene 80
Amsterdam 73
Bremen 73
Tokyo 71
Vienna 71
Warsaw 65
Elk Grove Village 64
Izmir 64
Hillsboro 59
Nuremberg 59
Brasília 58
Norwalk 56
Dublin 54
Tampa 53
Curitiba 51
Turku 51
Baghdad 50
Phoenix 48
Boardman 47
Kent 47
Utrecht 47
Chennai 46
Johannesburg 46
Montreal 44
Turin 44
Reggio Emilia 43
Brooklyn 42
Guangzhou 42
Lappeenranta 42
Toronto 42
Catania 41
Dong Ket 41
Hangzhou 41
Istanbul 41
Quito 41
Hải Dương 40
Florence 39
Guayaquil 39
Parma 39
Belo Horizonte 38
Mexico City 38
Biên Hòa 36
Manchester 36
Newark 36
Santiago 36
Brussels 35
Naples 34
Redwood City 34
Totale 34.300
Nome #
Fattori di rischio ambientali e occupazionali per la sclerosi laterale amiotrofica: uno studio caso-controllo di popolazione in Emilia Romagna e Sicilia. 552
FATTORI AMBIENTALI DI RISCHIO DELLA SCLEROSI LATERALE AMIOTROFICA: UNO STUDIO CASO-CONTROLLO DI POPOLAZIONE BASATO SU QUESTIONARI ANAMNESTICI 393
Isolated progressive cognitive impairment and depression in a patient with neuroradiological features suggestive of multiple sclerosis 389
Exposure to pesticides and risk of amyotrophic lateral sclerosis: a population-based case-control study 378
Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis 374
Pearls & Oy-sters: rapidly progressive dementia: prions or immunomediated? 369
Neurogenic T wave inversion in pure left insular stroke associated with hyperhomocysteinaemia 367
The study of levels from redox-active elements in cerebrospinal fluid of amyotrophic lateral sclerosis patients carrying disease-related gene mutations shows potential copper dyshomeostasis 366
Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study 355
Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations 348
Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study 343
Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study 332
Amyotrophic lateral sclerosis incidence following exposure to inorganic selenium in drinking water 328
Acute hemichorea as unusual first multiple sclerosis presentation 326
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy 323
Endozepines in recurrent stupor 319
Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. 315
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients 304
Selenium Neurotoxicity and Amyotrophic Lateral Sclerosis: An Epidemiologic Perspective 301
Epidemiologia e fattori ambientali di rischio della sclerosi laterale amiotrofica sporadica: metodologia di uno studio realizzato in ambiente gis. 300
Hsp90-mediated regulation of DYRK3 couples stress granule disassembly and growth via mTORC1 signaling 300
Pesticides, polychlorinated biphenyls and polycyclic aromatic hydrocarbons in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a case-control study 299
VCP AND AUTOPHAGOLYSOSOMAL PATHWAY: GUARDIANS OF PROTEOSTASIS AND STRESS GRANULE DYNAMICS. UNRAVELING THEIR IMPLICATIONS IN ALS 297
Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 293
Primary progressive multiple sclerosis and generalized myasthenia gravis: an uncommon association 292
Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis ? 292
Elevated Levels of Selenium Species in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients with Disease-Associated Gene Mutations 292
Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) 292
Central pontine myelinolysis and poorly controlled diabetes: MRI’s hints for pathogenesis 291
Comparison of questionnaire exposure data to land cover map from geographical information system to assess passive exposure to pesticides: a methodological study 289
Amyotrophic lateral sclerosis and sarcoidosis: a difficult differential diagnosis. 288
Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy 288
The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: A population based study in Modena, Italy 287
High‐frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial 286
Post-infectious sensory neuropathy with anti-GT1a and GQ1b antibodies associated with cold urticaria 286
Risk of ALS and passive long-term residential exposure to pesticides: a population based study. 285
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 284
Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study 280
ALS and FTD: Where RNA metabolism meets protein quality control 279
Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study 278
Amyotrophic lateral sclerosis: Prognostic indicators of survival 277
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM 277
Pesticidi e rischio di sclerosi laterale amiotrofica: il contributo della metodologia gis in uno studio in Emilia-Romagna e in Sicilia. 273
Internal carotid artery dissection: a rare cause of peripheral facial nerve palsy 271
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 266
Amyotrophic lateral sclerosis incidence following exposure to inorganic selenium in drinking water: A long-term follow-up 265
Selenium neurotoxicity in humans: Bridging laboratory and epidemiologic studies. 262
Tolosa-Hunt syndrome due to actinomycosis of the cavernous sinus: The infections hypothesis revisited 261
Bilateral posterior medullary and cervical stroke: a case report 261
Non-invasive and invasive ventilation and enteral nutrition for ALS in Italy. 261
Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence? 257
C9ORF72 and parkinsonism: Weak link, innocent bystander, or central player in neurodegeneration? 256
Rapidly progressive amyotrophic lateral sclerosis in a young patient with hereditary neuropathy with liability to pressure palsies 254
Pesticidi organoclorurati, bifenili policlorurati e idrocarburi aromatici policiclici nel liquido cefalorachidiano di pazienti con sclerosi laterale amiotrofica: uno studio caso-controllo 252
L’impiego della ventilazione meccanica non invasiva (VNI) nel trattamento dell’insufficienza respiratoria acuta (IRA) nei pazienti con sclerosi laterale amiotrofica (SLA) 252
A CASE-CONTROL STUDY OF NEUROTOXIC METALS IN CEREBROSPINAL FLUID AND RISK OF AMYOTROPHIC LATERAL SCLEROSIS 250
Population density and risk of Amyotrophic Lateral Sclerosis: an Italian population-based study. 248
Comment on 'Huntington's disease presenting as ALS' 246
Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries 245
Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis: Clinical Protocol and Evaluation of Microbiota Immunity Axis 245
The wide spectrum of cerebrotendinous xanthomatosis: Case report of a rare but treatable disease 244
Pearls & Oy-sters: Paroxysmal dysarthria-ataxia syndrome: Acoustic analysis in a case of antiphospholipid syndrome 244
Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment 241
Environmental risk factors for amyotrophic lateral sclerosis: methodological issues in epidemiologic studies 239
Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis. 239
Living near waterbodies as a proxy of cyanobacteria exposure and risk of amyotrophic lateral sclerosis: a population based case-control study 236
Sensory Loss Mimicking Cauda Equina Syndrome due to Cervical Spinal Lesion in a Patient with Clinically Isolated Syndrome 232
Environmental and occupational exposure to heavy metals and metalloid and development of amyotrophic lateral sclerosis: a population-based case control study in Emilia-Romagna and Sicily. 229
Influence of selenium on the emergence of neuro tubule defects in a neuron-like cell line and its implications for amyotrophic lateral sclerosis 229
BAG3 and BAG6 differentially affect the dynamics of stress granules by targeting distinct subsets of defective polypeptides released from ribosomes 229
I pesticidi quali possibili fattori ambientali di rischio nella sclerosi laterale amiotrofica: uno studio caso-controllo di popolazione in Emilia-Romagna. 228
Livelli di piombo, cadmio e mercurio nel liquido cerebrospinale e rischio di sclerosi laterale amiotrofica: uno studio caso-controllo. 226
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 225
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: A multicentre Italian study 225
Human microglia synthesize neurosteroids to cope with rotenone-induced oxidative stress 224
Spasmodic dysphonia as a presenting symptom of spinocerebellar ataxia type 12 221
Trace element species and amyotrophic lateral sclerosis with disease associated genetic mutations 219
Selenoprotein P Concentrations in the Cerebrospinal Fluid and Serum of Individuals Affected by Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment and Alzheimer’s Dementia 218
Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders 216
Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case control study 215
Exposure to inorganic selenium in drinking water and incidence of amyotrophic lateral sclerosis: a long-term follow-up of a natural experiment 214
Risk of ALS and passive residential exposure to pesticides: a population based study. 213
Do flavan-3-ols from green tea reach the human brain? 210
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial 209
Selenium species and heavy metals in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: a hospital-based case-control study 209
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 206
SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study 199
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 199
Reply to comment on “environmental and occupational risk factors of amyotrophic lateral sclerosis: A population-based case-control study” 198
Acute hemichorea as unusual first multiple sclerosis presentation: two case reports 195
Cadmium, lead and mercury levels in cerebrospinal fluid and risk of amyotrophic lateral sclerosis – A case-control study. 192
The NGS technology for the identification of genes associated with the ALS. A systematic review 192
Risk stratification of non-traumatic headache in the emergency department 191
Mitochondrial and Endoplasmic Reticulum Alterations in a Case of Amyotrophic Lateral Sclerosis Caused by TDP-43 A382T Mutation 190
Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 189
Insight into Elderly ALS Patients in the Emilia Romagna Region: Epidemiological and Clinical Features of Late-Onset ALS in a Prospective, Population-Based Study 185
A novel p.N66T mutation in exon 3 of the SOD1 gene: report of two families of ALS patients with early cognitive impairment 185
Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study. 183
Case report: p.Glu134del SOD1 mutation in two apparently unrelated ALS patients with mirrored phenotype 182
Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence 182
Totale 26.541
Categoria #
all - tutte 227.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021621 0 0 0 0 0 0 0 0 0 0 325 296
2021/20224.272 336 624 272 155 83 201 166 198 628 389 720 500
2022/20233.431 505 366 209 387 331 405 115 315 375 54 211 158
2023/20243.899 75 144 189 385 686 228 383 648 127 148 237 649
2024/202512.161 332 103 172 954 1.903 2.065 645 511 1.765 818 1.261 1.632
2025/202620.200 1.480 986 2.253 3.305 2.304 1.218 2.435 1.607 2.356 1.992 264 0
Totale 52.237